Year: 2019
Type: article
Abstract: For people with epilepsy, frontline treatment remains with anti-seizure drugs (ASDs), a group of over 20 different medicines available for this common, disabling brain disease. ASDs are effective in controlling seizures in approximately two-thirds of patients, but this leaves a very large number of people for whom seizures continue. This has devastating effects on quality of life and increases the risk for serious adverse events, including sudden unexplained death in epilepsy (SUDEP). In fact, the treatment gap is greater still.
Source: EBioMedicine
Author: David C. Henshall
Institution: Royal College of Surgeons in Ireland
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,500
OpenAlex ID: W2970080829
